United States · FDA National Drug Code directory
Zemaira
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0053-7201_a60040d6-46ed-4a3b-af7e-528a65b7fca7
- Product NDC
- 0053-7201
- Form
- KIT
- Composition / generic term
- alpha-1-proteinase inhibitor human
- Labeler
- CSL Behring LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20030708
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20) · 0053-7201-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →